AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bruserud, O
Gjertsen, BT
Foss, B
Huang, TS
Citation: O. Bruserud et al., New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches, STEM CELLS, 19(1), 2001, pp. 1-11
Authors:
Bruserud, O
Tjonnfjord, G
Gjertsen, BT
Foss, B
Ernst, P
Citation: O. Bruserud et al., New strategies in the treatment of acute myelogenous leukemia: Mobilization and transplantation of autologous peripheral blood stem cells in adult patients (vol 18, pg 343, 2000), STEM CELLS, 19(1), 2001, pp. NIL_7-NIL_7
Authors:
Berentsen, S
Tjonnfjord, GE
Brudevold, R
Gjertsen, BT
Langholm, R
Lokkevik, E
Sorbo, JH
Ulvestad, E
Citation: S. Berentsen et al., Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease, BR J HAEM, 115(1), 2001, pp. 79-83
Authors:
Bruserud, O
Gjertsen, BT
Von Volkman, HL
Citation: O. Bruserud et al., In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: Studies of native AML blasts and AML cell lines, J HEMATH ST, 9(6), 2000, pp. 923-932
Authors:
Bruserud, O
Foss, B
Abrahamsen, JF
Gjertsen, BT
Ernst, P
Citation: O. Bruserud et al., Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: Does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?, J HEMATH ST, 9(4), 2000, pp. 433-443
Authors:
Bruserud, O
Tjonnfjord, G
Gjertsen, BT
Foss, B
Ernst, P
Citation: O. Bruserud et al., New strategies in the treatment of acute myelogenous leukemia: Mobilization and transplantation of autologous peripheral blood stem cells in adult patients, STEM CELLS, 18(5), 2000, pp. 343-351
Authors:
Bruserud, O
Gjertsen, BT
Citation: O. Bruserud et Bt. Gjertsen, New strategies for the treatment of acute myelogenous leukemia: Differentiation induction - Present use and future possibilities, STEM CELLS, 18(3), 2000, pp. 157-165
Authors:
Cimpan, MR
Cressey, LI
Skaug, N
Halstensen, A
Lie, SA
Gjertsen, BT
Matre, R
Citation: Mr. Cimpan et al., Patterns of cell death induced by eluates from denture base acrylic resinsin U-937 human monoblastoid cells, EUR J OR SC, 108(1), 2000, pp. 59-69
Authors:
Cimpan, MR
Matre, R
Cressey, LI
Tysnes, B
Lie, SA
Gjertsen, BT
Skaug, N
Citation: Mr. Cimpan et al., The effect of heat- and auto-polymerized denture base polymers on clonogenicity, apoptosis, and necrosis in fibroblasts: denture base polymers induceapoptosis and necrosis, ACT ODON SC, 58(5), 2000, pp. 217-228
Authors:
Fladmark, KE
Brustugun, OT
Hovland, R
Boe, R
Gjertsen, BT
Zhivotovsky, B
Doskeland, SO
Citation: Ke. Fladmark et al., Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors, CELL DEAT D, 6(11), 1999, pp. 1099-1108
Authors:
Bruckheimer, EM
Gjertsen, BT
McDonnell, TJ
Citation: Em. Bruckheimer et al., Implications of cell death regulation in the pathogenesis and treatment ofprostate cancer, SEMIN ONCOL, 26(4), 1999, pp. 382-398
Authors:
Jensen, PH
Fladmark, KE
Gjertsen, BT
Vintermyr, OK
Citation: Ph. Jensen et al., Caspase I related protease inhibition retards the execution of okadaic acid and camptothecin induced apoptosis and PAI-2 cleavage, but not commitmentto cell death in HL-60 cells, BR J CANC, 79(11-12), 1999, pp. 1685-1691
Authors:
McDonnell, TJ
Bruckheimer, EM
Gjertsen, BT
Honda, T
Navone, NM
Citation: Tj. Mcdonnell et al., Molecular regulation and therapeutic implications of cell death in prostate cancer, CANC DRUG, 5, 1999, pp. 241-255
Authors:
Gjertsen, BT
Logothetis, CJ
McDonnell, TJ
Citation: Bt. Gjertsen et al., Molecular regulation of cell death and therapeutic strategies for cell death induction in prostate carcinoma, CANC METAST, 17(4), 1998, pp. 345-351
Risultati:
1-14
|